Age-related macular degeneration (AMD), a degenerative disease in the central macula
area of the neuroretina and the supporting retinal pigment epithelium, is the most common …

The field of neurobionics offers hope to patients with sensory and motor impairment.
Blindness is a common cause of major sensory loss, with an estimated 39 million people …

Many conditions affecting the heart, brain, and even the eyes have their origins in blood
vessel pathology, underscoring the role of vascular regulation. In age-related macular …

Age-related macular degeneration (AMD) is a multifactorial retinal disease characterized by
a progressive loss of central vision. Retinal pigment epithelium (RPE) degeneration is a …

Highlights•The development of efficacious ocular drug delivery systems to treat diseases of
the back of the eye faces many challenges due to the unique anatomy and physiology of the …

Cell replacement therapies are often enhanced by utilizing polymer scaffolds to improve
retention or direct cell orientation and migration. Obstacles to refinement of such polymer …

Age-related macular degeneration (AMD) is the leading cause of vision loss in geriatric
population. Intravitreal (IVT) injections are popular clinical option. Biologics and small …

Background Currently, no generally approved medical treatment can delay the onset of age-
related macular degeneration (AMD) or slow the progression of degenerative changes …

The retinal pigment epithelium (RPE) plays a key role in the development of many eye
diseases leading to visual impairment and even blindness. Cell culture models of …

Backgrounds Chronic inflammation in retinal pigment epithelial (RPE) cells is related to the
pathogenesis of retinal inflammatory blind causing diseases such as age-related macular …